↓ Skip to main content

A Novel Immune Marker Model Predicts Oncological Outcomes of Patients with Colorectal Cancer

Overview of attention for article published in Annals of Surgical Oncology, November 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
36 Mendeley
Title
A Novel Immune Marker Model Predicts Oncological Outcomes of Patients with Colorectal Cancer
Published in
Annals of Surgical Oncology, November 2015
DOI 10.1245/s10434-015-4889-1
Pubmed ID
Authors

Yufeng Chen, Ruixue Yuan, Xianrui Wu, Xiaosheng He, Yang Zeng, Xinjuan Fan, Lei Wang, Jianping Wang, Ping Lan, Xiaojian Wu

Abstract

The purpose of this study was to develop an in situ immune marker model to predict postoperative oncological outcomes in patients with colorectal cancer (CRC). Immunohistochemistry for 13 immune cell markers was performed on tumor tissue microarrays from 300 CRC patients who underwent curative resection from January 2000 to January 2006. Genetic algorithm was applied for the construction of an in situ immune marker model. The infiltration of CD3+ cells, CD45RO+ cells, and FOXP3+ cells, but not the infiltration of Tryptase+ cells, in the tumor was significantly associated with better clinical outcome in overall survival (OS) and disease-free survival (DFS) of CRC patients, as assessed by univariate analysis (P < 0.05). Based on the genetic algorithms, a total of 6 markers, including CD3, CD45RO, IL17, CD15, Tryptase, and FOXP3, were selected to construct an immune marker model. Our model was identified to have an independent predictive capability for both OS and DFS in Cox multivariable model (P < 0.001). This was further confirmed by the ROC analysis (area under curve: OS, 0.669; DFS, 0.684). The in situ immune marker model constructed in this study provides a novel approach to identify CRC patients who were at an increased risk for poor oncological outcomes.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 28%
Student > Ph. D. Student 5 14%
Researcher 4 11%
Student > Bachelor 3 8%
Other 2 6%
Other 2 6%
Unknown 10 28%
Readers by discipline Count As %
Medicine and Dentistry 15 42%
Biochemistry, Genetics and Molecular Biology 5 14%
Immunology and Microbiology 2 6%
Arts and Humanities 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 1 3%
Unknown 11 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2016.
All research outputs
#7,139,301
of 22,849,304 outputs
Outputs from Annals of Surgical Oncology
#2,440
of 6,476 outputs
Outputs of similar age
#112,518
of 386,465 outputs
Outputs of similar age from Annals of Surgical Oncology
#27
of 117 outputs
Altmetric has tracked 22,849,304 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 6,476 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 386,465 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 117 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.